InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Altimmune, Inc.

ALT Clue Score41
United States Fiscal year ends December CIK 0001326190 Results filed 12 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

15
Insider
Date
Role
Action
Shares
Price
Amount
Vipin K Garg
31 Aug 2022
President and CEO
Sell
20,000
$20.02
$400.32K
Vipin K Garg
12 Aug 2022
President and CEO
Sell
15,000
$15.06
$225.89K
John Gill
12 Aug 2022
Director
Sell
2,714
$15.00
$40.71K
Philip Hodges
1 Mar 2021
Director
Sell
6,000
$16.08
$96.48K
Philip Hodges
1 Dec 2020
Director
Sell indirect
1,227
$13.54
$16.61K
John Gill
30 Nov 2020
Director
Sell
8,425
$11.92
$100.43K
Philip Hodges
30 Nov 2020
Director
Sell
2,500
$12.00
$30.00K
Matthew Scott Harris
12 Nov 2020
Director
Sell
4,015
$10.02
$40.23K
Wayne Pisano
12 Nov 2020
Director
Sell
10,352
$9.90
$102.48K
Klaus Schafer
12 Nov 2020
Director
Sell
10,150
$9.91
$100.59K
Velocity Pharmaceutical Holdings LLC
15 May 2020
10% owner
Sell
30,622
$4.65
$142.39K
Velocity Pharmaceutical Holdings LLC
14 May 2020
10% owner
Sell
169,378
$4.81
$814.71K
Prescott Group Capital Management, L.l.c.
9 Dec 2016
10% owner
Sell indirect
436,324
$3.26
$1.42M
Prescott Group Capital Management, L.l.c.
8 Dec 2016
10% owner
Sell indirect
440,479
$3.25
$1.43M
Prescott Group Capital Management, L.l.c.
7 Dec 2016
10% owner
Sell indirect
477,829
$3.26
$1.56M
Show all 122 transactions →

What was left out

Form 4 filings counted 335
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 19
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 9
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 13,705,868
Sales filed before the plan box existed 14
History held since 7 May 2007